DWS
Dynamic Wealth Strategies Portfolio holdings
AUM
$139M
1-Year Return
11.21%
This Quarter Return
+7.94%
1 Year Return
+11.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$109M
AUM Growth
–
Cap. Flow
+$109M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
60.12%
Holding
245
New
245
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Vanguard Value ETF
VTV
|
$10.6M |
| 2 |
Vanguard Total Bond Market
BND
|
$8.08M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$7.71M |
| 4 |
Invesco S&P 500 Quality ETF
SPHQ
|
$7.18M |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$6.93M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 3.67% |
| 2 | Healthcare | 1.98% |
| 3 | Financials | 1.89% |
| 4 | Consumer Discretionary | 1.35% |
| 5 | Industrials | 1.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Phinia Inc
PHIN
$2.28B
| $9.97K | 0.01% |
+329
| New | +$9.97K |
|
202
CoStar Group
CSGP
$37.9B
| $9.44K | 0.01% |
+108
| New | +$9.44K |
|
203
Healthcare Realty
HR
$6.35B
| $9.41K | 0.01% |
+546
| New | +$9.41K |
|
204
Cardinal Health
CAH
$35.7B
| $9.37K | 0.01% |
+93
| New | +$9.37K |
|
205
Equinix
EQIX
$75.7B
| $8.86K | 0.01% |
+11
| New | +$8.86K |
|
206
Biogen
BIIB
$20.6B
| $8.54K | 0.01% |
+33
| New | +$8.54K |
|
207
Exact Sciences
EXAS
$10.2B
| $8.29K | 0.01% |
+112
| New | +$8.29K |
|
208
iShares Russell 1000 Growth ETF
IWF
$117B
| $8.19K | 0.01% |
+27
| New | +$8.19K |
|
209
Illumina
ILMN
$15.7B
| $8.08K | 0.01% |
+60
| New | +$8.08K |
|
210
Federal Realty Investment Trust
FRT
$8.86B
| $8.04K | 0.01% |
+78
| New | +$8.04K |
|
211
Rayonier
RYN
$4.12B
| $8.02K | 0.01% |
+252
| New | +$8.02K |
|
212
Independence Realty Trust
IRT
$4.22B
| $8.02K | 0.01% |
+524
| New | +$8.02K |
|
213
Global X Robotics & Artificial Intelligence ETF
BOTZ
$2.84B
| $7.92K | 0.01% |
+278
| New | +$7.92K |
|
214
Natera
NTRA
$23.1B
| $7.83K | 0.01% |
+125
| New | +$7.83K |
|
215
Dow Inc
DOW
$17.4B
| $7.79K | 0.01% |
+142
| New | +$7.79K |
|
216
Idacorp
IDA
$6.77B
| $7.37K | 0.01% |
+75
| New | +$7.37K |
|
217
Incyte
INCY
$16.9B
| $7.35K | 0.01% |
+117
| New | +$7.35K |
|
218
Merck
MRK
$212B
| $6.98K | 0.01% |
+64
| New | +$6.98K |
|
219
Corteva
CTVA
$49.1B
| $6.81K | 0.01% |
+142
| New | +$6.81K |
|
220
iShares Biotechnology ETF
IBB
$5.8B
| $6.66K | 0.01% |
+49
| New | +$6.66K |
|
221
Ligand Pharmaceuticals
LGND
$3.25B
| $6K | 0.01% |
+84
| New | +$6K |
|
222
Cytokinetics
CYTK
$6.34B
| $5.68K | 0.01% |
+68
| New | +$5.68K |
|
223
Kellanova
K
$27.8B
| $5.59K | 0.01% |
+100
| New | +$5.59K |
|
224
Carrier Global
CARR
$55.8B
| $5.57K | 0.01% |
+97
| New | +$5.57K |
|
225
Carnival Corp
CCL
$42.8B
| $5.56K | 0.01% |
+300
| New | +$5.56K |
|